Gene · 57045
Papers1,736
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,736
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Small extrachromosomal circular DNA harboring targeted tumor suppressor gene mutations supports intratumor heterogeneity in mouse liver cancer induced by multiplexed CRISPR/Cas9. | Genome Med | 2023 | 37803452 | PubTator, text mining | PubMed |
| Comprehensive genomic characterization of sporadic synchronous colorectal cancer: Implications for treatment optimization and clinical outcome. | Cell Rep Med | 2023 | 37794586 | PubTator, text mining | PubMed |
| Exosomal non-coding RNAs: Blueprint in colorectal cancer metastasis and therapeutic targets. | Noncoding RNA Res | 2023 | 37767111 | PubTator, text mining | PubMed |
| Methylation-Mediated Silencing of ATF3 Promotes Thyroid Cancer Progression by Regulating Prognostic Genes in the MAPK and PI3K/AKT Pathways. | Thyroid | 2023 | 37742107 | PubTator, text mining | PubMed |
| Bioinformatics analysis and identification of upregulated tumor suppressor genes associated with suppressing colon cancer progression by curcumin treatment. | Front Pharmacol | 2023 | 37731740 | PubTator, text mining | PubMed |
| Preclinical Evidence for the Use of Oral Mesenchymal Stem Cell-Derived Extracellular Vesicles in Bone Regenerative Therapy: A Systematic Review. | Stem Cells Transl Med | 2023 | 37715961 | PubTator, text mining | PubMed |
| Modern therapies of nonsmall cell lung cancer. | J Appl Genet | 2023 | 37698765 | PubTator, text mining | PubMed |
| FISH Panel for Leukemic Cutaneous T-Cell Lymphoma: Extended Patient Cohort Correlation with Blood Involvement and Clinical Outcomes. | JID Innov | 2023 | 37674691 | PubTator, text mining | PubMed |
| RAIDS atlas of significant genetic and protein biomarkers in cervical cancer. | J Gynecol Oncol | 2023 | 37668079 | PubTator, text mining | PubMed |
| JARID2 coordinates with the NuRD complex to facilitate breast tumorigenesis through response to adipocyte-derived leptin. | Cancer Commun (Lond) | 2023 | 37658635 | PubTator, text mining | PubMed |
| The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells. | Mol Cancer | 2023 | 37649123 | PubTator, text mining | PubMed |
| Natural and Synthetic Anticancer Epidrugs Targeting the Epigenetic Integrator UHRF1. | Molecules | 2023 | 37630248 | PubTator, text mining | PubMed |
| Synthetic viability induces resistance to immune checkpoint inhibitors in cancer cells. | Br J Cancer | 2023 | 37620409 | PubTator, text mining | PubMed |
| Current status and prospects of GREM1 research in cancer (Review). | Mol Clin Oncol | 2023 | 37614374 | PubTator, text mining | PubMed |
| Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk. | Nat Genet | 2023 | 37592023 | PubTator, text mining | PubMed |
| Non-Coding RNAs in Oral Cancer: Emerging Roles and Clinical Applications. | Cancers (Basel) | 2023 | 37568568 | PubTator, text mining | PubMed |
| Molecular mechanisms of multi-omic regulation in breast cancer. | Front Oncol | 2023 | 37564937 | PubTator, text mining | PubMed |
| Spotlight on the Expanding Role of miR-647 in Human Cancers. | Adv Biomed Res | 2023 | 37564440 | PubTator, text mining | PubMed |
| TEQUILA-seq: a versatile and low-cost method for targeted long-read RNA sequencing. | Nat Commun | 2023 | 37553321 | PubTator, text mining | PubMed |
| Prevalence and clinical implications of germline pathogenic variants in cancer predisposing genes in young patients across sarcoma subtypes. | J Med Genet | 2023 | 37536918 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57045/papers?page=7